Ā | All patients (nā=ā176) | EVO group (nā=ā90, 51.1%) | RTO group (nā=ā86, 48.9%) | P value |
---|---|---|---|---|
Age | 60.3āĀ±ā11.7 | 60.5āĀ±ā11.9 | 59.5āĀ±ā11.7 | 0.704 |
Male, n (%) | 125 (71.0) | 69 (76.7) | 56 (65.1) | 0.091 |
Etiology, n (%) | Ā | Ā | Ā | 0.395 |
Ā Hepatitis B virus | 50 (28.4) | 22 (24.4) | 28 (32.6) | Ā |
Ā Hepatitis C virus | 14 (8.0) | 7 (7.8) | 7 (8.1) | Ā |
Ā Alcohol | 83 (47.2) | 48 (53.3) | 35 (40.7) | Ā |
Ā Other | 29 (16.5) | 13 (14.4) | 16 (18.6) | Ā |
Diabetes, n (%) | 50 (28.4) | 24 (26.4) | 26 (30.2) | 0.298 |
Hepatocellular carcinoma, n (%) | 50 (28.4) | 24 (26.7) | 26 (30.2) | 0.600 |
Type of varices, n (%) | Ā | Ā | Ā | 0.470 |
Ā GOV2 | 99 (56.3) | 53 (58.9) | 46 (53.5) | Ā |
Ā IGV1 | 77 (43.7) | 37 (41.1) | 40 (46.5) | Ā |
Size of esophageal varices, n (%) | Ā | Ā | Ā | 0.244 |
Ā F0āF1 | 102 (58.0) | 47 (52.2) | 55 (64.0) | Ā |
Ā F2āF3 | 74 (42.0) | 43 (47.8) | 31 (36.0) | Ā |
Ā Hemoglobin, g/dL | 9.0āĀ±ā5.3 | 8.9āĀ±ā2.2 | 9.1āĀ±ā2.4 | 0.504 |
Ā Platelet count, Ć 109/L | 103.1āĀ±ā52.6 | 106.0āĀ±ā45.5 | 100.4āĀ±ā59.7 | 0.935 |
Ā INR | 1.43āĀ±ā0.32 | 1.44āĀ±ā0.36 | 1.41āĀ±ā0.71 | 0.362 |
Ā Alanine aminotransferase, IU/L | 38.5āĀ±ā49.7 | 42.1āĀ±ā60.9 | 35.1āĀ±ā34.5 | 0.418 |
Ā Total bilirubin, mg/dL | 2.1āĀ±ā3.2 | 2.3āĀ±ā3.7 | 1.8āĀ±ā2.5 | 0.154 |
Ā Serum albumin, g/dL | 2.9āĀ±ā0.2 | 2.9āĀ±ā0.5 | 3.0āĀ±ā0.5 | 0.274 |
Ā MELD score | 12.6āĀ±ā4.7 | 13.5āĀ±ā4.5 | 11.7āĀ±ā4.8 | 0.016 |
Ā Beta-blockers, n (%) | 52 (29.5) | 11 (12.2) | 41 (47.7) | <ā0.001 |